The process of activation-induced cell death (AICD) in T cells proceeds through a variety of mechanisms that engage different pathways of apoptotic cell death, involving on the one hand Bcl-2 family members that control the mitochondrial pathway of apoptosis, and on the other hand the death receptor-mediated apoptotic pathway. Our working hypothesis, forming a framework for the projects in this proposal, is that the different mechanisms of AICD combine in vivo to produce what we observe as peripheral T cell deletion, the clonal contraction of T cell numbers following initial expansion in response to antigen. In particular, our aims are to: 1. Compare potentially redundant modes of T cell autonomous AICD proceeding via restriction of survival signaling, and examine conditions under which they are engaged in immune homeostasis. We will explore the idea that if a T cell receives limited activation signals, the expansion and subsequent cell death that occur contributes to peripheral deletion of the population. We will test the role of a Bim-induced mitochondrial pathway in this phenomenon and explore how T cell """"""""programming"""""""" controls survival or cell death following activation. 2. Examine potentially redundant modes of T cell AICD that proceed via death ligand-receptor interactions, and examine conditions under which they are engaged in immune homeostasis. We will investigate T cell activation induced apoptosis mediated by death ligands, both where this is T cell autonomous and in the situation in which activated T cells induce nonlymphoid cells to express proteins that in turn kill the T cell. The former process will be analyzed in the context of TRAIL-mediated AICD that occurs when a CD8 T cell, primed in the absence of """"""""help"""""""" is restimulated. The latter process of """"""""inducible immune privilege"""""""" will be analyzed in terms of roles for the death ligand TRAIL in addition to FasL 3. Examine how glucose and AKT influence susceptibility to different pathways of AICD in an activated T cell. When a T cell is activated, survival signals are mediated by AKT/PKB. We will explore how AKT interferes with peripheral deletion and AICD, and will examine a pathway for AKT-mediated resistance to apoptosis. This pathway, involving GSK-3 and Hexokinase will be analyzed and test its roles in regulating the modes of AICD studied in the other aims. Our goals represent an integrated approach to understanding the processes of AICD and peripheral deletion and their relationships to the pathways of apoptosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI044828-07
Application #
6866369
Study Section
Immunobiology Study Section (IMB)
Program Officer
Winter, David B
Project Start
1999-03-01
Project End
2005-08-31
Budget Start
2005-03-01
Budget End
2005-08-31
Support Year
7
Fiscal Year
2005
Total Cost
$114,740
Indirect Cost
Name
La Jolla Institute
Department
Type
DUNS #
603880287
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Gong, Yi-Nan; Crawford, Jeremy Chase; Heckmann, Bradlee L et al. (2018) To the edge of cell death and back. FEBS J :
Gong, Yi-Nan; Guy, Cliff; Olauson, Hannes et al. (2017) ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences. Cell 169:286-300.e16
Tummers, Bart; Green, Douglas R (2017) Caspase-8: regulating life and death. Immunol Rev 277:76-89
Nogusa, Shoko; Thapa, Roshan J; Dillon, Christopher P et al. (2016) RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus. Cell Host Microbe 20:13-24
Quarato, Giovanni; Guy, Cliff S; Grace, Christy R et al. (2016) Sequential Engagement of Distinct MLKL Phosphatidylinositol-Binding Sites Executes Necroptosis. Mol Cell 61:589-601
Alvarez-Diaz, Silvia; Dillon, Christopher P; Lalaoui, Najoua et al. (2016) The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis. Immunity 45:513-526
Correia-Melo, Clara; Marques, Francisco D M; Anderson, Rhys et al. (2016) Mitochondria are required for pro-ageing features of the senescent phenotype. EMBO J 35:724-42
Rodriguez, D A; Weinlich, R; Brown, S et al. (2016) Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis. Cell Death Differ 23:76-88
Green, Douglas R (2015) Another face of RIPK1. EMBO Rep 16:674-5
Wan, Chi-Keung; Li, Peng; Spolski, Rosanne et al. (2015) IL-21-mediated non-canonical pathway for IL-1? production in conventional dendritic cells. Nat Commun 6:7988

Showing the most recent 10 out of 70 publications